Article
Conserved RNA–protein modules link early anthracycline responses to atrial fibrillation risk
2026-02-15
Abstract excerpt
<h4>ABSTRACT</h4> Anthracycline chemotherapeutics increase risk for cardiovascular disease. The early molecular events that link inherited risk to cardiac dysfunction remain poorly defined. We therefore exposed iPSC-derived cardiomyocytes from six individuals to three anthracyclines and an anthracenedione, which act as topoisomerase inhibitors (TOP2i) to induce DNA damage, and generated proteomics data following...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 9f4a3bee-b0c1-5e8c-9496-01d2f5c8802d
- DOI
- 10.64898/2026.02.15.706019
